Literature DB >> 2483420

Short- and long-term determinants of cardiovascular function and therapy: contributions of circulating and tissue renin-angiotensin systems.

V J Dzau1.   

Abstract

Cardiovascular function is regulated by short-term and long-term neurohormonal and autocrine-paracrine mechanisms that act synergistically or sequentially. Structural adaptive changes that occur progressively over time also contribute to the long-term outcome. The renin-angiotensin system (RAS) can operate as both an endocrine and an autocrine-paracrine (tissue) system. The endocrine component is involved with acute circulatory homeostasis, whereas the tissue RAS, we believe, participates in the tonic regulation of cardiovascular function and structure. Angiotensin converting enzyme (ACE) inhibitors exert both acute and long-term effects on blood pressure. The acute response is influenced by the activity of the endocrine RAS. On the other hand, the chronic response to ACE inhibition is determined by both serum and tissue effects. The reversal of hypertensive cardiovascular structural changes as well as the enhancement of renal sodium excretion by ACE inhibitors are important mechanisms of their long-term antihypertensive action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483420

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  14 in total

Review 1.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 2.  Angiotensin-converting enzyme inhibitors and coronary artery disease.

Authors:  J W Sayer; A D Timmis
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

3.  Nicotine modulates the renin-angiotensin system of cultured neurons and glial cells from cardiovascular brain areas of Wistar Kyoto and spontaneously hypertensive rats.

Authors:  Merari F R Ferrari; Mohan K Raizada; Debora R Fior-Chadi
Journal:  J Mol Neurosci       Date:  2007-09-25       Impact factor: 3.444

4.  The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.

Authors:  M Texter; R S Lees; B Pitt; R E Dinsmore; A C Uprichard
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

5.  Differential regulation of the renin-angiotensin system by nicotine in WKY and SHR glia.

Authors:  Merari F R Ferrari; Mohan K Raizada; Debora R Fior-Chadi
Journal:  J Mol Neurosci       Date:  2008-03-28       Impact factor: 3.444

Review 6.  Role of calcium and other ions in reperfusion injury.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

7.  Effect of antihypertensive drugs on cardiac enzymes in hypertension with myocardial infarction in NIDDM.

Authors:  M M Kamble; S M Vaidya
Journal:  Indian J Clin Biochem       Date:  2002-07

Review 8.  Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases.

Authors:  T F Lüscher; R R Wenzel; P Moreau; H Takase
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

Review 9.  Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.

Authors:  T F Lüscher; Z Yang
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 10.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.